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Executive Summary
Israel constitutes an interesting "laboratory case" of government intervention
in the realm of R&D policy. The recognized scientific and technological prow-
ess of the country was leveraged by extensive government support for com-
mercial R&D projects. R&D policies proved to be highly responsive to
changing circumstances, instituting innovative programs such as a govern-
ment-sponsored fund that jump-started the venture capital market, the techno-
logical Incubators program, a program for the support of generic projects
conducted by consortia of firms and academia, etc. The Israeli high-tech sector
has grown remarkably fast since the mid-1980s, and it is quite likely that gov-
ernment policies significantly contributed to its success. In this paper we re-
view in detail these policies as well as the challenges that confront them: the
design of alternative allocation schemes for R&D grants in view of a rigid bud-
get constraint, possible ways of departing from neutrality, the conditionality of
production in Israel, the difficulties in setting a policy target for R&D spending,
etc. We also lay out the more general issues and possible lessons for other coun-
tries that arise from the Israeli case: what should be the policy goal in terms of
total resources devoted to R&D, to what extent these policies should target
supply vs. demand in the market for R&D inputs, which types of support one
can envision in the context of R&D policies, and how these may be affected by
international spillovers.
I.Introductio&
Interest in R&D policy as an area of research has experienced recently a
marked upsurge within mainstream economics.2 This probably reflects
the perception that technical advances in information technologies (IT)
and related areas have been having a noticeable and sustained effect on
productivity growth in recent years (contrary to the previous uneasi-
ness in that respect vividly articulated in "Solow's paradox"). Since R&D
is driving the relentless flow of innovations that fuel IT and the "new80 Trajtenberg
economy," policies that affect R&D have thus become an attractive field
of inquiry Moreover, advanced economies all over the world see it as a
major goal to partake in the processes associated with the current wave
of innovations, and therefore their interest in R&D policy is immediate
and pragmatic.
Israel constitutes an interesting "laboratory case" of government in-
tervention in the realm of R&D policy. The recognized potential of the
country in scientific and technological prowess was leveraged by ex-
tensive government support for commercial R&D projects. The princi-
ple of neutrality that governs the main support programs ensured that
resources allocated responded to market signals rather than to bureau-
cratic directives. The Office of the Chief Scientist (OCS) of the Ministry
of Industry and Trade, the main conduit of R&D policies in Israel,
proved to be highly responsive to changing circumstances, instituting a
series of innovative programs beyond the regular matching R&D
grants (which still constitute the bulk of the support): "Yozma," the gov-
ernment-sponsored venture capital fund that jump-started the now
thriving venture capital market in Israel (and soon after terminated its
activities); the "Incubators" program, which responded to the opportu-
nities opened up by the mass immigration of scientists and skilled
workers from the Soviet Union; the "Magnet" program, designed to
support generic, precompetitive projects conducted by consortia of
firms and academia; etc.
And, indeed, the high-tech sector in Israel has flourished and grown
remarkably fast since the mid-1980s. Thus, for example, the number of
U.S. patents granted to Israeli inventors has more than tripled since
1985, Israeli high-tech exports grew eightfold in the past decade, etc.
Even if still tentative, available evidence suggests that government pol-
icies contributed significantly to this success in various ways, including
the vast expansion of capital markets, a positive effect of government
grants on productivity growth, and the further stimulation of R&D
spending (i.e., additionality).
However, the very success of the high-tech sector and presumably of
the underlying policies pose new challenges: a rigid cap on the subsi-
dies budget imposed in the late 1990s brought into sharp focus the
question of how to allocate scarce funds to a much larger pooi of sup-
port applications. Options include instituting a competitive ranking
system, randomization, and departures from neutrality. Still, the more
fundamental issue is that of setting a target R&D/GDP ratio, and deriv-
ing from it the optimal level of total R&D support. The rapid growthGovernment Support for Commercial R&D 81
of the R&D sector eventually ran into a highly inelastic segment of the
supply of qualified manpower, inflating wages for R&D personnel, and
thus restraining the actual growth of innovational efforts. Clearly, gov-
ernment policies will have to address both sides of the market for R&D
inputs if they are to be effective. Further open issues include the pay-
back provision, the requirement of production in Israel, and the extent
to which support should be aimed at more generic research.
It seems that the key to the apparent success of R&D policies in Israel
has been both the willingness of the government to take substantial
risks in allocating resources, and a remarkable extent of flexibility and
creativity in responding to rapidly changing needs.3 In order to be ef-
fective, R&D policy ought to mirror the sector to which itis
aimedrisktaking and irinovativeness are after all the hallmarks of
high tech. Government programs in this area should learn first and
foremost from their "clients" (without being coopted by them), rather
than from more traditional realms of policy. Given the inherent dyna-
mism of the high-tech sector, any policy that follows rigid rules is
bound to rapidly become either ineffective and/or inefficient. Much of
this is of potential relevance for the U.S., as well as for other countries
seeking an active role for government in the realm of advanced tech-
nology and innovation.
This paper provides the basic ingredients for the understanding of
R&D policy in Israel, and tries to draw from it wider lessons pertinent
to the design of R&D policy in general. Section II is primarily descrip-
tive: it opens with a review of the Office of the Chief Scientist (OCS)
main programs; the third subsection dwells on the Yozma venture capi-
tal program, and the fourth presents quantitative indicators of OCS ac-
tivities over time, followed in the fifth by a review of studies on the
contribution of the OCS, and an overview of the rise of the high-tech
sector in Israel with the help of patent data. Section III discusses in de-
tail the main policy issues that arise in this context: alternative alloca-
tion schemes for R&D grants, possible ways of departing from
neutrality, the conditionality of production in Israel, the desirabifity of
supporting Magnet consortia vs. regular R&D projects, the difficulties
in setting a policy target for R&D spending, etc.
Section IV lays out the more general issues and possible lessons for
other countries that arise from a close-up examination of the Israeli
case. Israel experimented, in a short period of time andwith great
intensity, with a variety of potent policy schemes and mechanisms.
Thus, the consequences of such policies, both beneficial and harmful,82 Trajtenberg
are more salient and hence lend themselves more easily to object
lessons in policy design. We group these issues into the following cate-
gories: (1) what should be the policy goal in terms of the total resources
devoted to R&D; (2) supply vs. demand, i.e. to what extent the policies
should target either side of the market (for R&D inputs); (3) which
types of support one can envision in the context of R&D policies; (4)
which sort of mechanisms should be considered for implement-
ing such policies; and (5) how should we think of R&D support in
view of international spillovers. Finally, Section V offers some closing
remarks.
II.Government Support for Industrial R&D in Israel: An
Overview4
Background
The beginning of government support for industrial (civilian) R&D in
Israel dates back to 1968: a government commission, headed by Prof.
Kachalsky, recommended the creation of the Office of the Chief Scien-
tist (OCS) at the Ministry of Industry and Commerce, with the mandate
to subsidize commercial R&D projects undertaken by private firms.
Support was confined until then to National R&D Labs, and to aca-
demic R&D, in addition to the weighty resources that were devoted to
defense-related R&D and to agricultural research. And indeed, indus-
trial R&D rose rapidly following the establishment of the OCS. Be-
tween 1969 and 1987 industrial R&D expenditures grew at 14% per
year, and high-tech exports grew from a mere $422 million in 1969 (in
1987 dollars), to $3316 million in 1987 (Toren 1990).
The next key development was the passing of the Law for the En-
couragement of Industrial R&D in 1985 (it has been revised several
times since). This is the main piece of legislation that has defined the
parameters of government policy towards industrial R&D ever since.
The stated goals of the legislation, to be implemented by the OCS, are
to develop science-based, export-oriented industries, which will pro-
mote employment and improve the balance of payments. In order to
do this, the legislation was supposed to provide the means to expand
and exploit the country's technological and scientific infrastructure,
and leverage its high-skilled human resources. The 1985 law may soon
undergo a significant revision, in view of the changes undergone by the
high-tech sector in the course of the last decade and the budgetary re-Government Support for Commercial R&D 83
straint of the late 1990s, which has resulted in excess demand for R&D
grants under the present system.
At the heart of the law is a program of financial incentives. Com-
panieswhether big corporations or small startupswhich meet cer-
tain eligibility criteria are entitled to receive matching funds for the
development of innovative, export-targeted products. The OCS funds
up to 50% of R&D expenses in establishedcompanies, and up to 66%
for startups. The OCS supports and administers a wide range of addi-
tional programs, the main ones being: (1) Magnet, a program to en-
courage precompetitive generic research conducted by consortia;(2) a
program of technological incubators; (3) various programsinvolving
bilateral and multilateral international R&D collaboration. We review
these programs here in some detail, and present quantitative indicators
of their performance.
A Review of OCS Programs5
Support for Standard R&D ProgramsThis is by far the largest program,
and administering it constitutes the main activity of the OCS. The
way it works is as follows. Qualifying firmssubmit grant applications
for specific R&D projects; these are reviewed by a Research Commit-
tee, and if they are approved (about 70% are), the applicants receive
a grant of up to 50% of the stated R&D budget for theproject. Success-
ful projects (i.e. those leading to sales) are required to repay the grant,
by paying back to the OCS royalties of 3% of annual sales,6 up to
the dollar-linked amount of the grant. Recipients of the R&D grants
have to abide by the following conditions: (1) the R&D project must be
executed by the applicant firm itself; (2) the product(s) that emerge
from the R&D project must be manufactured in Israel; (3) know-how
acquired in the course of the R&D may not be transferred to third
parties.7
The Research Committee, chaired by the Chief Scientist, is responsi-
ble for defining the conditions for granting aid (within the confines of
the 1985 law), and for reviewing the applications and selecting the re-
cipients. The committee is staffed both by qualified government
officials and by public representatives, but it relies on (outside) profes-
sional referees and advisers to review the applications. Decisions of the
Research Committee can be appealed before an Appeals Committee.
Grants of (up to) 50% of the total R&D costs are given to projects that
"lead to know-how, processes or systems for manufacturing a new84 Trajtenberg
product/process or substantially improving existing ones."8 Products
aimed at the military (export) market qualify for grants of up to 30%.
Grants covering 30% of R&D costs are available for projects leading to
improvements in existing civilian products, and 20% for improvements
of military (export) products. Startup companies qualify for grants
of up to 2/3 of R&D costs, with a ceiling of $250,000 a year for two
years.
Israel has a long-standing policy of encouraging the development of
an industrial base in peripheral areas (away from the main urban cen-
ters), which is reflected also in the R&D support programs. Thus, R&D
projects performed in the preferential peripheral areas ("Grade A De-
velopment Areas") are entitled to additional 10% grants: for civilian
projects that means grants of up to 60% (rather than 50% for the oth-
ers), and military projects are entitled to grants of up to 40% (rather
than 30% for the others).
The Magnet ProgramNotwithstandingtherapidgrowth of the
high-tech sector in Israel from the late 1960s onwards, it became clear
by the early 1990s that the industrial landscape in Israel was rather
fragmented and, with few notable exceptions, that Israeli industrial
companies were too small to be able to meet the escalating costs of de-
veloping new technologies in cutting edge fields. Moreover, Israel
boosted world-class research universities, but they operated largely in
isolation from surrounding industrial developments and needs, and
hence the vast economic potential embedded both in the highly
qualified academic manpower and in university research remained
largely untapped.9
Against this background the OCS established in 1993 the Magnet pro-
gram,1° to support the formation of consortia made of industrial firms
and academic institutions in order to develop generic, precompetitive
technologies." These consortia are entitled to multiyear R&D support
(usually 3 to 5 years), consisting of grants of 66% of the total approved
R&D budget, with no recoupment requirements. The consortia must
comprise the widest possible group of industrial members operating in
the field,'2 together with Israeli academic institutions doing research in
scientific areas relevant to the technological goals of the consortia.
Mindful of possible conflict with antitrust provisions, consortium
members must pledge to make the products or services resulting from
the joint project available to any interested local party, at prices that do
not reflect the exercise of monopoly power. Keeping with the mandateGovernment Support for Commercial R&D 85
to encourage precompetitive technologies, support to the consortium
ceases once the equivalent of the pilot plant stage isreached. That is,
the additional R&D required for the actual commercialization of the
products is not supported by Magnet, but the member companies may
then apply for regular grants from the OCS. Contrary to the regular
OCS support to industrial R&D projects, the Magnet program operates
on a competitive basis, that is, it is open to anynumber of proposals for
the formation of new consortia, and it selects only those that merit sup-
port on the basis of a ranking system.
By the end of 1999 there were 18 consortia in operation, commanding
a budget of about $60 million, and four additionalconsortia in various
stages of gestation. These consortia span a wide range oftechnologies,
primarily in communications, microelectronics, biotechnology, and en-
ergy They include ground stations for sateffitecommunications, digital
wireless communications, magnesium technologies, DNA markers,
0.25-micron devices, digital printing, etc.
The Incubators Program'3Technological incubators are support organi-
zations that give fledgling entrepreneurs an opportunity to develop
their innovative technological ideas and set up new businesses in order
to commercialize them. The program was introduced in theearly
1990s, when immigration from the former Soviet Union had reached its
peak. Many of these immigrants were scientists and skilled profession-
als who came to Israel with highly valuable human capital as well as
with plenty of ideas for innovative products. However, they were lack-
ing in virtually all other dimensions required for commercial success,
from knowledge of the relevant languages (e.g. Hebrew and English)
and of commercial practices in western economies, to managerial skills
and access to capital. Even though it targeted new immigrants, the pro-
gram is open to all.
The goal of the incubators is thus to support novice entrepreneurs at
the earliest stage of technological entrepreneurship, and help them im-
plement their ideas and form new business ventures. The premise is
that the technological incubator would significantly enhance the entre-
preneur's prospects of raising further capital, finding strategic part-
ners, and emerging from the incubator with businesses that canstand
on their own. Of course, this initial stage is the riskiest,and certainly in
the early 1990s there were virtually no other sources of finance in Israel
for such ventures. Since the mid-1990s there has been a growing influx
of venture capital, and hence it may well be that the purely risk-sharing86 Trajtenberg
function undertaken by this program may be less critical at present
than it was at its inception.
Each incubator is structured so as to handle 10-15 projects simulta-
neously, and provides assistance in the following areas: determining
the technological and marketing applicability of the idea, drawingup
an R&D plan and organizing the R&D team, raising capital and prepar-
ing for marketing, provision of secretarial and administrative services,
maintenance, procurements, accounting, and legal advice.'4
To qualify, projects must be aimed at developing an innovative idea
with export potential. The R&D team is to be made of three to six work-
ers, and the stay at the incubator is up to two years. The expectation is
that by the end of the period there will be a prototype andan orderly
business plan, and the project will be ready for further commercial in-
vestment and/or the involvement of a strategic partner. The budget for
each project is about $150,000 per year, for two years at most.'5 As with
the regular OCS program, the ensuing products have to be manufac-
tured in Israel, and if successful the entrepreneur has to eventually re-
pay the grant through royalties on sales.
Since its inception in 1991 and up to the end of 1998, the incubators
have managed close to 700 projects, of which about 200were still run-
ning as of December 1998 in 27 incubators across the country. Current
projects employ about 900 professionals, 70% of them recent immi-
grants, all with academic training and many with advanced degrees.
Of the 500 "graduating" projects, the success rate was about 50%, i.e.,
half managed to continue on their own, and the remaining half were
discontinued. About 200 projects (out of the successful half) managed
to attract additional investment, ranging from a mere $50,000 to several
million dollars. There are no predetermined technological areas for the
submission of projects. The actual distribution of projects by fields has
been as follows: electronics 27%, software 20%, medical instrumenta-
tion 17%, chemistry 27, miscellaneous 9%.
International CooperationThe relative advantage of Israel's high-tech
sector manifests itself primarily in its technological prowess in the
R&D stages. However, Israeli high-tech companies suffer from serious
difficulties in marketing abroad, primarily because they are geographi-
cally distant from the target markets, and because they are small. Thus,
cooperation with foreign companies active in the target markets is
likely to increase the ability of Israeli technology and products topene-
trate global markets. In that spirit, the Israeli government has signed inGovernment Support for Commercial R&D 87
recent years a number of bilateral R&D cooperation agreementswith
foreign governments. These are meant to encourage contacts between
Israeli and foreign companies leading to joint R&D, manufacturing,
and marketing. Foreign companies are expected to benefit by gaining
access to advanced Israeli technology, andthey are also likely to derive
commercial advantages from Israel's simultaneous free trade agree-
ments with the U.S. and the European Union (few countries enjoy
both).
Joint ventures between Israeli and foreign companies, authorized by
the relevant authorities in the respective countries, are entitled to aid
from both governments according to the regulations prevailing in each.
Bilateral agreements exist already with a number of countries, includ-
ing the U.S., Canada, France, Holland, and Spain; their implementation
is the responsibility of the Chief Scientist, assisted by TheIsraeli Indus-
try Center for R&D (MATIMOP).
The Israel-U.S. Binational Industrial Research and Development
Foundation (BIRD) was founded in the early 1980s under a convention
signed by both governments. Its objective was to promote and support
joint, nondefense, industrial research and development activitiesof
mutual benefit to the private sectors of the two countries. The Founda-
lion has an independent legal status, and its main office is in Israel. Its
Board of Governors is composed of representatives of the U.S. and Is-
raeli governments.
BIRD participates in the funding of joint R&D via conditional grants
amounting to 50% of the project costs, up to a maximum of $1.5million
per project. If a project succeeds, BIRDreceives royaltiesa pretax ex-
pense to the payerup to a maximumof 150% of the conditional grant.
Only in cases where a project fails and there are no sales are the compa-
nies exempted from repaying the grants. BIRD also helps Israeli or
American companies identify partners in order to enable them tosub-
mit joint R&D programs for funding by the Foundation.
Additional Support ProgramsBeyond the main programs just de-
scribed, the OCS offers a variety of additional assistance programs,
aimed at specific stages of the innovation cycle or at particular seg-
ments in the progression from an innovative idea to afull-fledged com-
mercial enterprise. Thus for example, the Bridging Aid program offers
support for the transition between R&D and manufacturing,including
the construction of prototypes and the operation of pilot plants;
another program supports studies of the market potential for new88 Trajtenberg
technologies, prior to the investment of large sums in the R&D stage;
etc. Although much smaller in budget, these programs may play an im-
portant role in making sure that potentially viable projects don't fall in
between the cracks along the hazardous way towards successfulcom-
mercial implementation.
Jump-Starting the Venture Capital Market
From the start, government support to R&D was meant not only to
incentivize innovative activities, but also to compensate for the lack of
well-developed capital markets. The Israeli stock exchangewas a small
operation up to the mid 1990s, and did not offer a significant channel
for raising funds; foreign capital did flow in to some extent, but it took
primarily the form of direct investments, not of liquid funds; Israeli
savings were handled mostly by the concentrated banking sector, and
in particular by highly regulated mutual and providence funds that in-
vested primarily in government bonds. With few exceptions, the
high-tech sector could not rely on local sources of finance and, given
the impediments at the time, for the most part could not raise capital
abroad either. Thus, the R&D subsidies provided by the OCS fulfilled
also an acute financial need, but they could hardly makeup for the
dearth of other financial sources. In addition, Israeli high-tech firms
were traditionally strong in technology but lacking in managerial ex-
pertise and competencies.
Recognition of these needs brought the government to establish in
1992 the Yoznia (meaning "initiative" in Hebrew) program, whichwas
meant to jump-start the venture capital market in Israel. Yozma estab-
lished a number of venture capital funds, thatwere initially funded by
the government but that included also local and foreign private inves-
tors. The "carrot" offered to the latter was the issuing of options to buy
Yozma's shares in these funds in 5 years' time at a predetermined price.
Yozma managed to attract prominent foreign multinational investors
(Advent of Boston, GAN of France, Daimler-Benz of Germany, the
China Venture Management of Taiwan, etc.), which brought along not
only their financial resources but most importantly their expertise.
Shortly after its establishment, Yozma managed to setup 10 venture
capital funds and helped raise close to $200 million.
Contrary to other government programs, Yozma had at inceptiona
fixed life expectancy of 7 years. In fact, though, its rapidsuccess al-
lowed it to terminate its activities early on: in 1997 its direct investmentGovernment Support for Commercial R&D 89
portfolio was privatized, and thus its mission came to an end. Since
then the venture capital market in Israel has boomed, with over 80
funds in operation, having raised close to $5 billion for hundreds of
startups. In addition, capital markets have greatly expanded in Israel
since the mid-1990s, and international access has improved dramati-
cally. For example, Israelis the foreign country with the largest number
of IPOs in Nasdaq (closely contested by Canada). This burst of funding
sources imply that government support to R&D can confine itself to its
original role of subsidizing innovation in order to bridge the gap be-
tween the social and the private rate of return, without having to take
on a further financial role.
The case of Yozma is remarkable in that the government reacted
quickly to a pressing need, and did so in a way that ensured a limited
and transitory role for itself (with a "self-destruct" clock of 7 years).
Yozma acted purely as a catalyst and marketmaker, in an area where
surely governments have no comparative advantage. On the other
hand, the government did not presume that the "invisible hand" will
just do its job unaided, but took on the role of one-time entrepreneur to
make it happen in a timely fashion.
Quantitative Indicators of OCS Support Programs
Systematic data on the OCS are hard to obtain, and in fact there are vir-
tually no official statistics on the activities and budgets of the OCS
since its creation in 1969. The lack of data has been detrimental to the
functioning of the OCS and has surely impaired the formulation of
R&D policy at all levels. The OCS has long been aware of the problem,
and efforts are being made to remedy it in a fundamental way. The data
presented here are based on reports supplied to us by the OCS in Janu-
ary 2000,16 but there still remain questions regarding some of the
figures, and hence these should be seen as tentative data, which require
further scrutiny.
Table 3.117 shows the OCS budget since 1988, as well as paybacks,
and the amounts allocated to the Magnet and Incubators programs. To-
tal R&D grants administered by the OCS increased steeply since 1988
and up to the mid-1990s, then increased slightly until 1997, and have
changed little since. Paybacks rose very fast throughout the whole peri-
od,'8 and in fact their weight in the OCS budget has increased dramati-
cally from a mere 7% in 1988 to 32% by the late 1990s. What this means
is that about 1/3 of the present OCS budget just constitutes "recycling"90 Trajtenberg
Table 3.1
The OCS Budget 1988-2000 (in current $ million)
a R&D grants minus paybacks.
b Estimates.
of funds within the high-tech sector, and not government subsidy to
R&D. The net subsidy is given in column 4 under "Net grants": these
peaked in 1995, and have since declined slightly (certainly more so in
real terms). Furthermore, if we subtract the funds allocated to the Mag-
net and the Incubators programs, we can see that the net subsidy to the
regular OCS grants program has declined very substantially since 1995
(by about 25% up to 1999, in nominal terms).
The number of firms applying to the OCS for grants went from 450 in
1990 to about 600 in 1999, after reaching a peak of 777 in 1994. The de-
cline since 1994 includes, quite surprisingly, startups that applied for
the first time.'9 Given the rapid growth in the overall number of
startups throughout the economy,2° the decline in the number of
first-time startup applicants may well reflect a change in their funding
strategy, that is, more of them may prefer to rely on venture capital
funds rather than on the OCS (without strings attached with regard to
production in Israel or the eventual sale of the firm to foreign corpora-
tions).21 In the course of the 1990s a total of 2380 firms applied for sup-
port from the OCS for the first time. This is a large number by any
standard, and offers further indication of the prominent role that the
OCS has played in fostering the high-tech sector.
Tables 3.2-3.4 show the distribution of projects and grants by size of

















1988 120 8 0.07 112
1989 125 10 0.08 115
1990 136 14 0.10 122--
1991 179 20 0.11 159 0.3 3.6
1992 199 25 0.13 174 3.7 16
1993 231 33 0.14 198 4.6 23
1994 316 42 0.13 274 10 28
1995 346 56 0.16 290 15 31
1996 348 79 0.23 269 36 30
1997 397 102 0.26 295 53 30
1998 400 117 0.29 283 61 30
1999 428 139 0.32 289 60 30
2000b 128 0.32 267 70 30Government Support for Commercial R&D 91
Table 3.2
Number of projects approved by size of firms
N0t including incubator projects.
Table 3.3
Grants by size of firm
N0t including incubator projects.
Table 3.4
Average grant per project by size of firm
allot including incubator projects.
Number
Small and medium
Grants (millions of current $)
Average grant (thousands of current $)
Year Large
Small and medium
Overall mean All Startupsa
1995 658 322 174 227
1996 703 366 210 252
1997 778 466 248 317
1998 590 463 211 314
1999 490 643 278 368




1995 144 202 62 346
1996 149 199 66 348
1997 161 236 67 397
1998 157 243 60 400
1999 99 329 68 428
Total 710 1209 323 1919
1995 219 1303 357 1522
1996 212 1170 314 1382
1997 207 1045 270 1252
1998 266 1009 285 1275
1999 202 960 245 1162
Total 1106 5487 1471 6593
Year Large All Startupsa Total92 Trajtenberg
the past 5 years, declining from a high of 1500 in 1995 to 1200 in 1999.24
On the other hand the average dollar amount per project increased
from $227,000 in 1995 to $368,000 in 1999 (in nominal terms). Notice
though that the average size of projects for large firms declined quite
steeply, whereas that of small and medium firms increased a great deal.
Large firms commanded about 40% of grants (in dollar terms) for most
of the period, but their share of the budget declined steeply in 1999, to
23 % 25,26
The OCS and the Rise of the High-Tech Sector
So far we have described the structure and programs of the OCS, and
presented quantitative indicators of its activities over time. The natural
questions that one would like to pose now are those related to the im-
pact of the OCS: To what extent has the OCS fulfilled the goals envision
by the 1985 law? What effect have the various OCS programs had on
the high-tech sector and on the economy at large? And so forth. First
we review existing econometric studies, then we discuss some eco-
nomic indicators contrasting R&D-intensive sectors with traditional
ones, and lastly we present an overview of the rise of the high-tech sec-
tor in Israel with the help of patent data.
Review of Econometric StudiesThe consensus in Israel is that the OCS
indeed played a key role in the emergence and development of the
high-tech sector, a role that went beyond the mere administration of
grants. There have been various studies in Israel examining inter alia
the impact of R&D expenditures on productivity at the firm level
(Bregman, Fuss, and Regev 1991; Griliches and Regev 1995; Bregman
and Merom 1998). They all find that the returns to R&D have been
high, and in particular significantly higher than investments in physi-
cal capital. However, these studies do not address the effect of govern-
ment support per se.
If one could assume that OCS grants brought about higher total R&D
outlays (this is commonly referred to as additionality), then the findings
of high returns to R&D would imply also positive returns to govern-
ment support. Capital markets were extremely limited in Israel during
the early stages of development of the high-tech sector there (i.e. in
the 1970s and 1980s), and hence it is very unlikely that R&D grants
supplied by the OCS would have crowded out private R&D funds
back then. Later on, though, internal reform as well as internationalGovernment Support for Commercial R&D 93
openness greatly increased the availability of funds to industry.
bringing back to the forefront the additionality issue, certainly for the
1990s.
The basic conundrum posed by additionality is the obvious lack of
counterfactuals (i e "what would the recipient firm have done had it
not received an R&D subsidy?"), which effectively means the lack of
appropriate controls (i.e. data on nonrecipients that are otherwise simi-
lar to the recipients). Several recent papers have tried a variety of ap-
proaches to deal with it (see for example Busom 2000 and Walisten
2000), but the jury is stifi out both on method and on stylized facts.27
Feldman and Kelley (2000) come closest to having an appropriate con-
trol group: they followed both winners of Advanced Technology Pro-
gram (ATP) grants and applicants that failed to receive grants. Survey-
ing both types of firms, they find primz facie evidence of additionality:
nonawardees tend not to pursue the proposed projects by themselves,
awardees are more successful in seeking additional funding for the
projects, etc.
Lach (2000) carefully examines this issue for a sample of Israeli man-
ufacturing firms that performed R&D during the period 1991-95, and
finds that the R&D subsidies granted by the OCS in fact stimulated
long-run company-financed R&D expenditures. According to his esti-
mates, an extra dollar of R&D subsidies increases long-run com-
pany-financed R&D by 41 cents (evaluating the effect at the mean of
the data). Thus, total R&D outlays increase at the margin by 1.41 dol-
lars: the full amount of the subsidy, plus the additional, induced effect
of 41 cents. However, it is not clear to what extent those results are ro-
bust, either to the choice of specification or to that of instruments; in
fact, in other specifications Lach finds little or no additionality. The
problem resides mostly in the paucity of the data (there are not many
firms with any given set of characteristics at any point in time that can
serve as controls for those receiving subsidies) and in the difficulty in
finding appropriate instruments.
Taking a different track, Griliches and Regev (1999) examine whether
the source of R&D funds per se (private vs. OCS grants) makes a differ-
ence in productivity (once again in a panel of firms), regardless of
additionality. They find that it does: government-funded R&D appears
to be significantly more productive than privately financed R&D, by a
surprisingly large margin. The reason may be rooted in the ability of
the OCS to pick winners, and/or in the fact that the very process of ap-
plying for grants may compel firms to self-select projects, use more94 Trajtenberg
structured preassessment and planning techniques, etc. Finally, an un-
published study commissioned by the OCS itself examined the contri-
bution of OCS grants to sales, exports, and the like, relying on detailed
data from the OCS and on an extensive survey of firms (Michiol, 1999).
The study finds very high "multipliers" per dollar of OCS support,
higher for small firms than for large ones; however, the study is careful
to point out its limitations, particularly given the lack of a suitable con-
trol group.
The evidence thus far available from these studies, then, provides ec-
onometric support, albeit limited, to the presumption that OCS grants
have had a positive and significant effect on productivity in R&D-in-
tensive sectors, and through them on the economy as a whole. Still,
there is a long way to go in that respect, if only because a major ingredi-
ent of the rationale for government support to R&D, namely spillovers,
has not been investigated at all. Beyond the aforementioned studies,
we present now some evidence on the development of the high-tech
sector itself, with the implicit understanding that the OCS was one of
the main drivers behind the rise of this sector. We do that in two ways:
first, we briefly recount reports from the Bank of Israel on the perfor-
mance of technologically advanced sectors vis-à-vis traditional ones;
second, we present an overall view of innovation in Israel, relying on
comprehensive and highly detailed information on Israeli patenting in
the U.S.
Aggregate Sectorial Indicators28Responding to the rapid changes in the
composition of industry and in particular the raise of the high-tech sec-
tor, the Research Department of the Bank of Israel introduced in the
mid-1990s a new classification of the manufacturing sector: it was di-
vided into "advanced," "traditional," and "mixed" sectors, according
to the quality and composition of the labor force (e.g. the percentage of
scientists and engineers), the quality of the capital stock, and the rela-
tive size of the R&D stock.29 Table 3.5 presents selected indicators ac-
cording to this classification.
The advanced sectors outperformed the two other categories in vir-
tually all dimensions during the reported period (1995-98). The differ-
ences between them increased substantially in 1997 and 1998, a period
of rather severe recession. During those years the advanced sectors
grew at a rate of 6% per year, whereas the others remained stagnant or
declined. Similarly, exports from advanced sectors grew at a stunning
18.5% per year, whereas the mixed sectors exhibited an anemic 3%
growth, and the traditional sectors declined 1.4%. Thus, it is clear thatGovernment Support for Commercial R&D 95
Table 3.5
Performance indicators by type of sector, 1995-98
Source: Bank of Israel, Annual Report for 1998, table B 10 (p. 56).
Israeli manufacturing is shifting away from traditional industries and
into technologically advanced, export-oriented sectors.
A further indicator is the rapid growth of high-tech exports in
the course of the last decade, both in value terms and as a share of total
exports, as shown in table 3.6. High-tech exports include communica-
tions, monitoring, medical and scientific equipment, electronic com-
ponents, office machines, and computers.
Innovation in Israel: Patent Indicators30Patent-based statistics are often
used as indicators of innovative activity. Indeed, their very wide cover-
age, long time series, and richness of detail make them a unique and
compelling data source for the study of technical change. There are also
limitations: not all innovations are patented, both because of failure to
meet patenting requirements and because of strategic considerations.
We present in this section an overview of innovation in Israel based on
all patents awarded to Israeli inventors in the U.S. during the period
1968-97 (over 7000 patents), as well as patents of inventors in compari-
son countries. Given that the high-tech sector in Israel is overwhelm-
ingly export-oriented, and that the U.S. is a prime destination for those
exports, there is reason to believe that Israeli patents issued in the U.S.
are representative of the main technological trends and patterns in
Israel.
Figure 3.1 shows the number of successful Israeli patent applications
in the U.S. over time, starting in 1968. The growth in the annual num-
ber of patents has been very impressive, starting from about 50 in the
Indicator Period







Production 1995-96 8.0 6.3 5.9
1997-98 6.0 0.3 1.8
Labor productivity 1995-96 3.5 2.4 4.2
1997-98 4.5 0.6 2.2
Capital stock 1995-96 10.7 6.4 9.7
1997-98 10.0 6.1 6.8
Exports 1995-96 9.0 10.5 2.7








Source: Israeli Central Bureau of Statistics.
Appflcatlon Year
Figure 3.1
Israeli patents in the U.S. 1968-97, by application year.
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late 1960s, to over 600 in the late 1990s. However, the process was not
smooth, but was characterized by big swings in growth rates. Particu-
larly striking are the two big jumps that occurred in the second half of
the period: from 1983 to 1987 the number of patents doubled, and it
doubled again from 1991 to 1995.31 Figure 3.2 shows industrial R&D ex-
penditures (in constant 1990 dollars) along with patents.32 There is
clearly a (lagged) comovement of the two series, as manifested for ex-
ample in the following simple Pearson correlations33:
R&D R&D(-1) R&D(-2) R&D(-3)
Thus, patents lead R&D by 2-3 years, and the correlation is stronger
in rates (i.e. when using logs) than in levels. Looking in more detail,
there is a striking run-up in R&D from 1981 to 1986 (in particular, R&D
expenditures more than doubled between 1980-81 and 1984-85), fol-
lowed by the doubling of patents between 1983 and 1987. This is the
period that saw the emergence of the high-tech sector, and that is well
reflected in both series. In 1986-88 we see a decline in the level of R&D
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Figure 3.2
Israeli patents and industrial R&D.
700
Patents 0.850 0.877 0.884 0.883
log (patents) with log (R&D) 0.890 0.901 0.922 0.92898 Trajtenberg
then again a sustained increase through the earlymid nineties that an-
ticipates the second big jump in patenting.
Although we do not have official figures for R&D grants from the
OCS prior to 1988, available figures indicate that the behavior of the
time series for grants is very close to that of total R&D industrial
spending (see for example Griliches and Regev 1999, table 6). In partic-
ular, from 1981 through 1986 OCS grants also doubled, they flattened
during 1986-88, and they grew fast again up to the mid-1990s (see table
3.1 for the latter). It is clear then that industrial R&D expenditures are
closely linked (with a reasonable lag) to patents, and so are R&D grants
awarded by the OCS. Further research is needed to unravel the joint
dynamics.
International Comparisons We resort to international comparisons in
order to put in perspective the overall level and trend over time in Is-
raeli patenting. We do that with respect to three different groups of
countries: (1) The G7: Canada, France, Germany, Italy, Japan, the U.K.,
and the U.S.; (2) a reference group: Finland, Ireland, New Zealand, and
Spain34; and (3) the Asian tigers: Hong Kong, Singapore, South Korea,
and Taiwan.
Figures 3.3-3.5 show the time patterns of patents per capita for Israel
vs. each of the above groups of countries. We normalize the number of
patents by population, simply because this is a widely available and ac-
curate statistic that provides a consistent scale factor.35 Figure 3.3 re-
veals that Israel started virtually at the bottom of the G7 (together with
Italy), but by 1987 it had climbed ahead of Italy, the U.K., and France
and was on a par with Canada. In the early-mid nineties it moved
ahead of Canada and (the unified) Germany, thus becoming third after
the U.S. and Japan. Using civilian R&D as deflator for these countries
shows a similar result. Thus, there is no question that Israel had surged
forward and placed itself in the forefront of technologically advanced
countries, at least in terms of (normalized) numbers of patents.
The comparison with the reference group reveals that the only coun-
try that is "game" is Finland, which has followed a pattern virtually
identical to Israel. The other three countries are well behind, and have
remained at the bottom without any significant changes over time. As
to the Asian tigers, we can see immediately that Taiwan has grown ex-
tremely rapidly since the early eighties, actually surpassing Israel in
1997. And indeed, Taiwan is widely regarded today as a high-tech
powerhouse, after being associated with low-tech, imitative behavior
for a long time. South Korea seems to be embarked on a similar path.
By contrast, Hong Kong and Singapore remain well behind.0
Figure 3.3
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Figure 3.5
Patents per capita: Israel vs. the Asian tigers.
Comparisons based on normalized patent counts notwithstanding,
many aspects of the innovation process require a critical mass, and for
those purposes it is the absolute size of the innovative sector that
counts, as proxied here by the (absolute) number of patents. Israel has
still a long way to go in those terms: it stands well below all of the G7
countries, and is about one-fourth the size of Taiwan and South Korea.
The question is whether there are forces in the Israeli economy capable
of keeping the momentum going for the high-tech sector, bringing it up
to the size required and ensuring its long-term viability The stagnant
budgets awarded in recent years to the OCS are not a good omen in
that respect.
The Technological Composition of Israeli Patented Innovations The U.S.
Patent Office has developed over the years an elaborate classification
system by which it assigns patents to some 400 main patent classes,
and over 150,000 patent subclasses. We have developed recently a new
classification scheme, aggregating these 400 patent classes into six
main categories: the three traditional categories chemical, mechanical,
and others; the two upcoming categories computers and communications
and drugs and medicine; and the in-between category electrical and elec-
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quite stable in the U.S.: the traditional categories were the highest,
whereas drugs and medicine and computers and communications ac-
counted just for a tiny fraction, up to 5% each. Starting in the early
1980s the top three fields decline, whereas the bottom two surge for-
ward, with computers and communications accounting by 1994 for
over 15% of all patents.
The pattern for Israel is similar, except that the changes are more
abrupt. The most striking development is the surge of computers and
communications from about 5% in the 1970s (as in the U.S.), to a full
25% by 1994 and beyond. Likewise, drugs and medicine doubles its
share from 10% to 20%. The flip side is the much more pronounced de-
cline in the traditional categories, with chemical exhibiting by far the
sharpest drop, from 40% at the beginning of the period to less than 10%
by 1996. The composition of innovations has thus changed dramati-
cally in Israel, and seemingly in a healthy way, in that they are in tan-
dem with worldwide changes in technology, except that Israel is
experiencing them at an accelerated rate.
Who Owns and Who Benefits from Israeli Patented Innovations?The
patent-based indicators mentioned so far suggest that Israel's innova-
tive performance has been quite impressive. However, the question
arises whether the Israeli economy can take full advantage of the inno-
vations generated by Israeli inventors, in view of the composition of
the patent assignees, i.e. of the owners of the intellectual property
rights to those innovations. In fact, just about half of all Israeli patents
granted in the last 30 years are owned by Israeli assignees (corpora-
tions, universities, or government): the rest belongs to private inven-
tors (unassigned patents) or to foreign assignees. This percentage is
lower than in most of the comparison countries, certainly much lower
than the corresponding figure for the G7 countries except Canada (lo-
cal assignees made 74% of patents in the U.S., 96% in Japan). The pre-
sumption is that (local) economic gains from innovation are correlated
with this figure, and furthermore, that they are correlated with the per-
centage of patents owned by local corporations (just 35% in Israel). The
trend is encouraging, though: the percentage of patents that belong to
Israeli corporations has been rising steadily, and stands now at close to
50%.
The overall picture that emerges from these patent indicators is thus
mixed: on the one hand Israel exhibits a rapidly growing and vibrant
innovative sector, which has achieved an impressive international
standing. On the other hand, the Israeli economy has still a way to go102 Trajtenberg
in order to achieve critical mass and to realize the economic benefits
embedded in those innovations.
III. R&D Policy in IsraelA Reassessment36
Having described the programs and basic ingredients of R&D policy in
Israel towards the industrial sector, we now undertake to examine the
contents of that policy. Unfortunately, the lack of rigorous empirical re-
search in this area hampers the formulation of sound, long-term, and
well-grounded policies. Nevertheless, we shall scrutiiiize the policies
currently in place and their implementation mechanisms, and evaluate
proposals for changes in them that are called forth by recent develop-
ments. This should be seen just as an opening salvo, aimed primarily at
fostering public debate in this area (see also Teubal (1999), who lays out
a detailed proposal for an R&D strategy for Israel).
First, we look at the system by which grants are allocated: with the
recent imposition of a rigid budget constraint on the OCS, the present
system is basically untenable, and hence we examine various alterna-
tives that will incorporate this new reality. Second, we examine a series
of policy issues that go beyond the allocation of funds: the payback sys-
tem, the conditionality on production in Israel, etc. Third, we look in
detail into the Magnet program, and the rationale for supporting it vs.
the regular OCS grants. Fourth, we review the difficulties in setting a
policy target for R&D spending, and lastly we ask whether govern-
ment policy should be aimed also at the supply side or the market for
R&D personnel, rather than just keep subsidizing the demand side.
Rethinking the Rules of the Game in View of a Rigid Budget
Constraint
Background The R&D Law in Israel does not address the thorny issue
of how to allocate a (rigid) budget for R&D support if the demand for
such support exceeds the budget provision. That is, the OCS support
program was not meant to be competitive, and in principle it should
provide R&D subsidies to all projects that pass the eligibility criteria.
The latter are based on technological and commercial feasibility, and
other procedural considerations. Projects are judged one by one, and
there is no attempt to rank them or otherwise establish a funding prior-
ity. The paramount principle of neutrality, which has been a corner-
stone of R&D policy in Israel since the late 1960s, also precludes
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In 1997 the projected demand for R&D support greatly exceeded the
budget provision (by about 50%, i.e. some $200 million), and the Trea-
sury refused to consider any substantial increase in the OCS budget to
accommodate such demand.37 An impasse ensued, bringing a great
deal of uncertainty to the working of the OCS and to the high-tech sec-
tor as a whole. A committee was formed to try to find a way out of the
crisis. After months of deliberations the committee could not reconcile
the conflicting forces at play: on the one hand the imperatives of the ex-
isting law, the expectations of the high-tech sector based on it, and the
perceived need to expand the R&D support budget in order to accom-
modate and foster the success of the high-tech sector; and on the other
hand the sudden imposition of a rigid budget constraint that did not al-
low for any growth of demand.
The result has been ad hoc tinkering both with the OCS budget and
its way of operation, in order to keep the system running without solv-
ing the underlying issues. More importantly, this protracted crisis
made it clear that the R&D law as is, and the implementation mecha-
nisms in place, are in need of extensive revision in view of the explo-
sive growth of the high-tech sector (as well as the rapid changes that
took place within the sector), and the pressure that puts on the R&D
support budget in an era of fiscal restraint.38 Following is a discussion
of the set of policy issues that lie at the core of this conundrum. The ba-
sic premise underlying the discussion is that, if current procedures are
left unchanged, demand for R&D support will exceed present level
budgets by wide margins,39 and hence there is an urgent need to design
a suitable allocation mechanism.
There are essentially two ways to go about allocating a fixed budget
to projects that request support in excess of available resources. The
first is to depart from the principle of neutrality in some dimension, the
second to design an allocation mechanism that will do the job. Of
course, the two are not mutually exclusive, and one could have'a com-
bination of both. We consider each in turn, starting with the latter.
Allocation Schemes for the Regular OCS Program of R&D GrantsUntil
now the system has been such that all eligible projects are supposed to
be supported, and in principle the support should be equal across pro-
jects (in percentage terms). The eligibility criteria entail checks of tech-
nological and commercial feasibility (or "viability"), the good standing
of the applicants, and other administrative criteria. There are three
main options for moving away from this system: (1) to adjust continu-
ally the support rates or the eligibility criteria so as to meet the budget104 Trajtenberg
constraint; (2) to implement a competitive ranking system; (3) ran-
domization.
The first option entails adjusting the support rates or the eligibility
criteria with every new budget so as to meet the budget constraint. The
major drawback is of course the uncertainty that such a policy shift will
introduce, greatly impairing the ability of firms to plan ahead (cer-
tainly in the long term). In addition, this would make the whole sup-
port system vulnerable to political manipulation.
The second option simply means that projects would have to com-
pete against each other for scarce support funds (as happens with the
Magnet program). There will be a ranking system, and the funds wifi
be allocated from the top down until the budget is exhausted. A serious
issue that will almost certainly arise in such a context is whether or not
the system is compatible with neutrality, in view of the fact that any
ranking system will be extremely hard to implement across fields, so
that the ranking would have to be done primarily within fields.4° How-
ever, it may be that in any case the system will have to move away from
neutrality (see below).
The last option is some sort of randomization, that is, to chose at ran-
dom from the set of projects that pass some eligibility threshold (as in
the present system), up to the point where the budget constraint is met.
We shall not analyze this option in any detail, simply because it would
seem that it is (at least at present) politically infeasible.41 Thus, it seems
that the only viable alternative at this point is to implement some sort
of competitive ranking system, as suggested above, and combine it
with a conscious departure from neutrality.
Departures from Neutrality As already mentioned, one of the hall-
marks and basic premises of the OCS support programs all along has
been neutrality, that is, the OCS does not select projects according to
preferred fields or any such criteria, but responds to demand that arises
spontaneously from industry, It is fair to say that this policy has been
eminently successful, since it basically reinforced existing competen-
cies and emerging comparative advantage. Moreover, it avoided one of
the main dangers of any industrial policy, namely, the picking of win-
ners by government officials
However, the fiscal constraint on the overall support budget implies
that the OCS may have to depart from neutrality in any case, in which
case it is certainly better to do it explicitly as a result of serious analysis,
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OCS could opt for nonneutral allocation policies: according to fields,
and according to type (or rather size) of firms.42 As already suggested,
such departures could be made part of a revamped allocation scheme
(e.g. by adopting a competitive ranking system).
Departing from neutrality with respect to technological fields is al-
ways dangerous, since it implies guessing future technological and/or
market developments, and deciding by committee what is better left to
the market. Thus, one should avoid it except if there are some glaring
market failures that need to be remedied. There is room to believe that
may be the case at present in Israel with the field of biotechnology. Is-
rael has a very talented and plentiful workforce in life sciences. Yet, this
pool of human capital in one of the most dynamic technological areas
at present, and potentially one of the most important future growth ar-
eas, has yet to make a mark on industry (i.e. in biotech). Thus, there is
room to consider taking a more active and entrepreneurial attitude to-
wards this sector (not necessarily by channeling more funds to it), but
that requires further study.
The second possible departure from neutrality is differential support
to firms of different sizes. We discuss this option now in more detail.
Departing from Neutrality: Large vs. Small FirmsIn principle, the sup-
port policies of the OCS do not make any distinction among types of
firms with respect to eligibility for the existing flat rate of support (50%
of the approved R&D budget).43 In practice, though, and as described
in Section II, the support for large firms during the past two years has
been reduced, reversing the previous trend whereby a handful of very
large firms (large by Israeli standards) accounted for a large proportion
of the total support dispensed. However, this de facto change has been
essentially an ad hoc response to budgetary pressures (and hence is
likely to be temporary), and not a well-formulated policy reassessment.
Thus, we still have to examine whether the principle of equal support
to all firms regardless of size is a reasonable policy. In other words, the
question is whether the rationale for R&D support (in terms of market
failures etc.) holds equally for small and large firms. A brief review of
the basic economic rationale for support of R&D reveals that indeed
there is room to (re)consider the prevailing policy, and reduce the rate
of support to large firms vs. smaller ones.
First, the larger is the firm, the more able it is to internalize the
spilovers that it generates, and hence the smaller will be the diver-
gence between the social and the private rate of return on the R&D that106 Trajtenberg
it performs. One of the main goals of government support to private
R&D is precisely to bridge the gap between the two rates of return: ab-
sent that support, firms will do too little R&D (relative to the socially
desirable level), and hence the support is meant to encourage them to
increase that amount past what is profitable according to the private
rate of return on it. However, the more a firm manages to capture the
spifiovers that stem from its R&D projects, the less room there is to sub-
sidize it on that basis. Size matters in that respect: small firms are
hardly able to capture the externalities that they generate, but that abil-
ity increases as they grow larger.
A further rationale for government support of R&D has to do with
risk and risktaking. First, the degree of risk of an R&D project from an
economy-wide point of view may be lower than that perceived by pri-
vate firms; or, closely related, the risk premium demanded by private
investors may be higher than warranted, because of asymmetric infor-
mation. Second, the degree of risk aversion by private investors maybe
higher than the social rate. As a result, the market may provide for too
little risktaking in R&D, and hence government support would encour-
age firms to move in the socially desirable direction.
The point in the present context is that there might be substantial dif-
ferences in this respect between small and large firms. First, problems
of asymmetric information are usually more acute for younger/smaller
firms, and hence the risk premium that smaller firms are required to
pay is often much higher. Second, R&D projects undertaken by small
firms are, ceteris paribus, riskier than if done by larger firms, even if
they are exactly the same in terms of technological goals. This is so be-
cause younger/smaller firms are disadvantaged relative to large firms
in terms of a wide range of competencies and experience that are com-
plementary to R&D: in marketing, pure management, access to comple-
mentary know-how, etc. Thus, there is more room to subsidize
risktaking by small firms than by larger ones.
Lastly, imperfections in capital markets usually affect small firms
more than large firms. First, the availability of internal financing, which
has been shown to be important in the context of R&D, is normally less
constraining for older/larger firms than for smaller ones. Second, ac-
cess to global capital markets is easier/cheaper for larger firms. Thus,
government support to R&D meant to bridge those imperfections
ought to be channeled more towards small firms than to larger ones.
These considerations suggest that there is room to consider support-
ing small firms at higher rates than larger firms. One could envision theGovernment Support for Commercial R&D 107
following support structure: Going startups (up to 5 M$ salesY': 66%;
small to medium-size firms (5-100 M$ sales): 50% (as at present); large
firms (over 100 M$ sales): 33%. This is of course just an examplea se-
rious proposal would have to pay a great deal of attention to the cutoff
levels, the implications for the budget, etc.
Further Policy Issues
The Payback Scheme (Recoupment) At present the policy is that success-
ful projects (i.e. projects that eventually lead to sales) are required to
pay back to the OCS the amount of support received, but the payback
cannot account for more than a small percentage of annual sales.45 The
idea is that this way the OCS shares the risk of the R&D projects (effec-
tively lowering the risk premium that private firms have to pay), and
overcomes possible imperfections in capital markets by offering easily
accessible finance. Moreover, it subsidizes R&D both in that it demands
zero interest on the conditional loan, and (as already mentioned) in
lowering the risk premium. There are, however, serious drawbacks to
such a system:
Since the payback obligation applies to sales that stem directly from
the projects supported, this immediately creates moral hazard prob-
lems with regard to how projects are defined, and all sorts of perni-
cious incentives for choosing how to relate products and sales to
projects.
The previous issue implies that the OCS and the firms supported
find themselves engaged in an antagonistic, confrontational situa-
tion that is detrimental to the efficient functioning of both.
As we have seen in Section II, the importance of payback funds in the
overall OCS budget is growing steeply over time, and there is a dan-
ger of political opportunism in this respect, namely, that the commit-
ment to R&D support may diminish, but in the short run that could
be disguised by increased reliance on payback funds in order to sup-
port new projects.
Beyond those issues, the payback scheme may have had the unin-
tended consequence of blurring the real intent of the R&D Law, obscur-
ing the true extent of the support budget, and hence the commitment of
the government to R&D. As we have seen, such support is warranted
for good economic reasons, which indeed call for a subsidy to R&D.108 Trajtenberg
Contrary to some widely held perceptions, the intent and rationale of
the R&D Law is not for the government to assume just a financing role,
in view of imperfections in existing financial markets in Israel. The
main intent is to bridge the gap between the social and the private rate
of return to R&D, and that calls for a straight subsidy. The recent avail-
ability of venture capital and the opening of the Israeli economy to for-
eign capital markets may reduce the effective cost of capital and
perhaps also the risk premiums to Israeli high-tech firms. However,
that has nothing to do with the fact that these same firms generate
spillovers to the Israeli economy that they can only partially appropri-
ate, a fact that calls for subsidizing R&D.
Thus, there is room to consider the phasing out of the payback
scheme, or at least the offering of an alternative track consisting of a
lower subsidy rate but without a payback proviso. If the payback
scheme is eliminated, the R&D grants given by the OCS will become
strictly and overtly what they were designed to be, namely, a straight
subsidy, hence doing away with the hazards of political opportunism.
The Conditionality of Production in IsraelThe R&D Law stipulates that
if the OCS extends support to an R&D project, the innovation resulting
from it should be produced in Israel. In fact, the law states as one of its
goals to increase employment in that way. It should be clear that such
conditionality might lead to serious allocational inefficiencies. Denote
by c1 the costs of producing in Israel, by cA the costs of producing
abroad, and by S the R&D subsidy. It is trivial to show that, if c1 -
c4 < S. the firm will choose to take the R&D subsidy, execute the project
in Israel, and produce there even though production in Israel is more
costly than abroad. If the inequality is reversed, then the project will be
carried out abroad entirely (including the R&D). Denote the cost disad-
vantage by 5' = C1 - cA. In the case where c1 - CA < 5, we can see that
the R&D subsidy is in fact composed of two parts: S = S' + (S = S').
The first part, S', is then a subsidy to production, not to R&D, and only
the second part is a true R&D subsidy. The larger is the gap between
production costs in Israel and those abroad, the more the R&D grants
are in fact subsidizing inefficient production that quite likely would
not be otherwise located in Israel.
Thus, there is room to consider the elimination of this provision of
the law: there is no strict economic rationale for it, and it leads to pro-
duction inefficiencies. Israel presumably has a comparative advantage
in R&D, not in the assembly of "boxes" containing the sophisticated in-
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ality is repealed, then the effective R&D subsidy could be increased
without increasing the actual amount of funds disbursed. Denote by S
the new subsidy; then one could have S - 5' <SN < S. Of course, the
government can legitimately try to encourage local employment, and
see the R&D Law as one of the means to do so. In that case, though, it
should be clear that part of the grants constitute in fact an employment
subsidy, and should not be counted as R&D support.
Policy Changes and Support for Large Firms We suggested above that
the rate of support for large firms could be set at a lower level than that
for smaller firms. However, we envision the implementation of these
policy changes as a comprehensive package. In that case, while lower-
ing the nominal rate of support to large firms, the effective rate may ac-
tually increase, both because of the phasing out of recoupment and
because of the conditionality to produce in Israel. This latter provision
is likely to affect larger firms more than smaller ones, since for larger
firms the options and opportunities to produce abroad are much more
extensive. As to the payback scheme, it is also likely that the percentage
of successful R&D is higher for larger firms, and hence that the pay-
back burden is also disproportionally higher for them. On both ac-
counts, then, larger firms stand to gain from the repeal of these
provisions, thus compensating for the lower support rate.
Ongoing Economic Assessment and Policymaking The drawing of sound
economic policies towards R&D, innovation, and the high-tech sector
is of paramount importance for the Israeli economy. At present,
though, there is no body in charge of setting such policies, and hence
things happen in a rather haphazard way, in response to successive
pressures and developments. What is needed is an economic policy
unit, probably at the OCS, with the following mandate: (1) to collect
and organize in a comprehensive and coherent way the data needed
for policymaking; (2) to set procedures for the ongoing evaluation of
the effectiveness of the OCS policies; (3) to evaluate, research, and dis-
cuss long-term policies. It is interesting to note that the Advanced Tech-
nology Program in the U.S., which is the closest to the OCS in terms of
intent, has such a unit as an integral part of its mission and mandate.
The Magnet Program vs. the Regular OCS Fund
As already mentioned, the Magnet program supports consortia
of industrial firms and academia, aimed at developing "generic,110 Trajtenberg
precompetitive technologies" common to the members of the consor-
tia. Magnet finances two-thirds of the R&D budget of the consortia
with straight grants, and there is no payback obligation. Contrary to
the regular program of the OCS, Magnet selects consortia on a corn peti-
tive basis, and allocates in this manner a budget of about 60 M$/yr to
the winning consortia.
One of the phenomena that underlies the need for the Magnet pro-
gram is the fact that R&D efforts in the Israeli high-tech sector have
been rather fragmented. That is, this sector is characterized by the ex-
istence of a very large number of small to medium firms, a handful of
large ones (but none with sales of over $1 billion), and a great deal of
turnover.46 There is no question that the vitality, the daring, and some
spectacular successes of the sector owes in no small measure to these
features, which provide favorable conditions for an accelerated Dar-
winian process. On the other hand, these same features call into ques-
tion the ability of the sector, and of the Israeli economy as a whole, to
reap long-term economic benefits from its own success. The recent
sales of a series of highly successful Israeli companies to foreign corpo-
rations are just one of the manifestations of this syndrome.
Fragmentation was perhaps unavoidable, certainly in the initial
stages of development of the high-tech sector, since the overwhelming
majority of high-tech firms grow out of startups established by single
technological entrepreneurs. Moreover, most of them aim (at least ini-
tially) at narrowly defined market niches. As the sector moves on,
though, size matters: in order to tackle larger markets and contemplate
accordingly longer-term projects, there is need for larger entities, and
that in turn calls for various forms of cooperation, joint ventures, merg-
ers, and acquisitions. However, for reasons that we do not profess to
understand, too little seems to be happening in that respect internally
(i.e. within Israel). In fact, we witness time and again not only failures
of cooperation, but even serious informational failures, in the sense
that potential partners are unaware of the existence of each other,
and/or of the potential for mutually beneficial cooperation.
Given this background, the importance of Magnet may lie not so
much in its formally stated mission (i.e. supporting generic R&D) as in
the fact that it fosters cooperation, it facilitates the creation of larger
(sometimes virtual) entities, it disseminates information about possibil-
ities for joint ventures, and it encourages individual firms to seek such
information. Contrary to deeply rooted belief, one cannot just assurne
that if there are profitable opportunities for cooperation they will nec-
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It is therefore quite certain that the economic rationale for govern-
ment support to R&D is strongest for a program such as Magnet, both
for the aforementioned reasons and for more traditional (but equally
important) ones, namely, that it deals with generic projects and
strongly emphasizes the sharing and dissemination of information.
Thus, there is room to consider the expansion of Magnet as a policy in-
strument, perhaps increasing the share of the overall R&D support
budget that it administers. There are a host of specific issues having to
do with the way the Magnet program is implemented, but that is be-
yond the scope of this paper.
How Much Support to R&D?
Is There a Basis for Setting a Policy Target?As we have seen in the sub-
section "Jump-Starting the Venture Capital Market" of section I, the
budget of the OCS has stabilized since 1997 at a level of about $400 mil-
lion per year, following a decade of rapid growth. The high-tech sector
has been lobbying for further increases, claiming that OCS grants play
a key role in lowering R&D costs and hence in fueling innovation, in
making Israeli companies more attractive to foreign investors, and in
compensating for geopolitical disadvantages.48 The government has re-
fused, arguing that the massive influx of venture capital and other
forms of financing in recent years (primarily IPOs in Nasdaq) prove
that there is hardly a need for further R&D subsidies, and that in fact
there may be room to reduce them. The result has been an impasse in
policymaking towards this sector, and the concomitant uncertainty has
probably had a detrimental effect on it.
Stepping out from the political economy aspects of the issue, the
question is, how should we think about setting a desirable level of
R&D support? Is the current level of $400 million appropriate, and if
not, what sort of policy gradient should the government pursue? As
we shall see, these questions pose serious conceptual and empirical
difficulties that are well beyond the scope of this paper. Thus, we shall
content ourselves just with outlining these difficulties, in the hope that
they will soberly inform the policy debate and prompt further, much
needed research.
The basic premise underlying the sort of neutral, across-the-board
R&D subsidies that the OCS dispenses is that, left to its own, the mar-
ket will undertake too little R&D. If so, the question of how much R&D
subsidies the government should give out amounts to asking how
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R&D. If this optimal R&D allocation exceeds the actual one, the R&D
support budget should then be set so as to close the gap between them.
Thus, there are two distinct problems to tackle: assessing the presumed
gap between actual and optimal R&D spending in the economy, and
devising ways to bring the economy to the desired level (and perhaps
mix) of R&D spending through a subsidy program such as that of the
OCS. Notice that the latter necessitates first and foremost a reliable esti-
mate of the additionality factor.
Unfortunately, existing literature provides little guidance regarding
the assessment of the gap, be it in modeling or in empirical implemen-
tation. One notable exception is Jones and William (1998): they take the
social rates of return to R&D estimated in a series of studies by
Griliches and others (e.g. Grifiches 1994, Scherer, 1982), and use them
(as well as their own estimate) in the context of a Romer (1990) growth
model to derive the optimal R&D/GDP ratio. Jones and Williams find
that the U.S. devotes far too little resources to R&D, and that even tak-
ing a lower bound of 30% for the social rate of return to R&D, the opti-
mal R&D/GDP ratio may be 2 to 4 times higher than the present one of
about 2.2%.
It is not clear, though, whether the results of Jones and Wiffiams and
the concomitant policy implications can be readily extended to other
countries. First, the optimal R&D/GDP ratio depends critically on the
ratio of the social rate of return to R&D, to the economy-wide real rate
of return (e.g. the long-term return on the stock market). On both ac-
counts a country such as Israel may differ substantially from the U.S.
Second, Jones and Williams consider R&D in the context of a closed
economy; in an open economy, whereby some of the benefits from an
own country's R&D spifi over to other countries (see for example Coe
and Helpman 1995), the notion of a "social" rate of return is far less
clear.
Eaton, Gutierrez, and Kortum (1998) provide further support to
the notion that countries may be underinvesting in R&D. They laid
out a detailed model of the R&D process and of the transmission of
research outcomes across countries (based on Eaton and Kortum 1996),
and proceed to calibrate it for the European Union countries and to
simulate its responsiveness to various policy levers. One of their con-
clusions is that increasing research activity in most European countries
could make a substantial contribution to productivity levels not only in
the E.U. but throughout the OECD. However, Eaton, Gutierrez, and
Kortum stop short of endorsing the channeling of additional resources
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R&D/GDP ratio that could serve as an actual target for policy in any
specific country. Still, their conclusions are congruent with a policy
gradient of increasing R&D/GDP ratios, at least for most European
countries.
R&D Ratios as Yardsticks for Policy Much of the discussion in the liter-
ature on R&D policy is cast in terms of various R&D ratios, particularly
the ratio of total civilian expenditures on R&D to GDP (in short,
R&D/GDP). Countries compare themselves with each other in terms
of these ratios, and often set targets based on averages for various refer-
ence groups (the European Union, the OECD, etc.) This is so not only
because the amount of resources devoted to R&D obviously cannot be
divorced from total resources available, but also because there is a great
deal of uncertainty in this respect, and hence political feasibility and
expedience often requires such linkages.49 Israel is no exception, and
indeed Israel's standing vis-à-visother countries in terms of
R&D/GDP ratios figures prominently in the current debate. While they
surely may play a useful role in informing policymaking, we would
like to argue that these ratios should be considered with great caution
as yardsticks for policy, both because of measurement problems, and
because of the importance of critical mass in the R&D context.
The measurement of R&D expenditures poses serious challenges to
statistical agencies, both because it is very difficult to delimit what
counts as R&D, and because of difficulties in computing appropriate
deflators (see the appendix). Recent revisions by the Israeli Central Bu-
reau of Statistics (CBS) of business sector R&D (BSRD), based on an ex-
panded definition of R&D, resulted in a drastic increase in the
estimates of BSRD and hence on the R&D/GDP ratio, which have of
course profound policy implications. As to R&D deflators, preliminary
computations suggest that if we were to deflate by an index based on
wages of R&D personnel, the growth of BSRD would be much slower
than estimated, again having serious policy repercussions.
The second problem with international comparisons of R&D ratios
for policy is that of critical mass. Contrary to other areas, where the rel-
ative amount of resources may constitute a good enough yardstick
(such as in health or education), what determines the effect of R&D on
the economic performance of the economy is in many cases the absolute
amount invested. That is so basically because there are substantial
indivisibilities in R&D at both the micro and macro levels. At the level
of individual projects and/or firms, a wide range of technological areas
require the commitment of relatively large amounts of R&D in order to114 Trajtenberg
make these projects at all feasible (in other words, the minimum
efficient scale of projects in such areas is large). Thus, the development
of communication satellites requires R&D budgets of hundreds of mil-
lions of dollars, and so do new pharmaceuticals.
At the economy-wide level, the conduct of R&D requires a vast array
of supporting infrastructure and services, the availability of adequate
manpower (not only scientists and engineers but also supporting per-
sonnel of various sorts), and of financial institutions and markets. All
of these will come into being only if enough R&D is being carried out
to justify the emergence of the required infrastructure, venture capital
institutions, etc. Moreover, the ability of firms conducting R&D to cap-
ture the spillovers generated by others in the same region or country
depend as well on the existence of a sufficiently large nearby R&D sec-
tor. This latter factor can be critical for the chances of the high-tech sec-
tor in the country to become a "Silicon Valley." Thus, it is hard to
compare R&D/GDP ratios for countries that vary a great deal in size,
particularly when the differences are so extreme as between the U.S. or
Japan and Israel.5°
Furthermore, the extent to which comparisons of R&D ratios are in-
formative (and potentially telling from a normative point of view) de-
pend inter alia on the growth strategy that the countries being
compared have chosen. Israel embarked long ago in a growth path that
relies heavily upon the promotion of high-tech, export-oriented sec-
tors, reflecting its perceived comparative advantage in high-skilled la-
bor. By contrast, countries such as Spain or New Zealand, while
comparable to Israel in terms of current GDP per capita, have chosen a
very different path (recall section II and figure 3.4). Thus, while a
R&D/GDP ratio of about 1% for Spain might be adequate given its
growth strategy. Israel's much higher ratio may still be below the mark.
In order to gain further perspective on the issue of absolute vs. rela-
tive size of expenditures in R&D, consider table 3.7, where we list the
leading industrial R&D performers in the U.S., and compare them with
Israel as a whole. Thus, in 1997 the absolute amount of resources allo-
cated to civilian R&D in Israel was $3129 miffion, of which $2006 mil-
lion was in the business sector.51 That same year eight of the leading
industrial R&D performers in the U.S. spent over $2 billion on R&D,
each of them more than Israel's industrial sector as a whole. To put it
differently, all of Israel's business sector R&D amounted to the R&D
done by Pfizer, and was slightly less than the R&D done by Johnson
and Johnson. If we took instead Israel's total civilian R&D, that wouldGovernment Support for Commercial R&D 115
Table 3.7
The 15 leading industrial R&D companies in the U.S., and Israel R&D expenditures, in
Source: NSF science and engineering indicatorstop 500 firms in R&D by industry
category, 1999. http:www.nsf.gov/sbe/srs/nsf003Ol.
place Israel as number 4, just in between IBM and Lucent. These gaps
are well reflected also in patent statistics (see Trajtenberg 1999): Israeli
inventors were granted in 1997 a total of 653 patents, of which slightly
less than half (about 320) went to Israeli corporations. By contrast, that
same year IBM was granted 1758 patents, Motorola 1151, Intel 407,
Hewlett-Packard 537, General Electric 667, and so forth.
Prop Up Demand, or Stimulate Supply?
As mentioned in section II, the basic premise underlying Israeli R&D
policy has been all along that Israel enjoys a comparative advantage in
high-tech, science-based industries, because of the abundance of highly
skilled labor and scientific personnel. This, coupled with the presump-
tion that the market is likely to underinvest in R&D, provides the ratio-
nale for the direct subsidization of industrial R&D, as done through




R&D (M$) R&D/sales (%)
1 General Motors 8200 4.9
2 Ford Motor 6327 4.1
3 IBM 4307 5.5
Israel's total civilian R&D 3129
4 Lucent Technologies 3100 11.8
5 Hewlett-Packard 3078 7.2
6 Motorola 2748 9.2
7 Intel 2347 9.4
8 Johnson&Johnson 2140 9.5
Israel's business sector R&D 2006
9 Pfizer 1928 15.4
10 Microsoft 1925 16.9
11 Boeing 1924 4.2
12 Chrysler 1700 2.9
13 Merck 1684 7.1
14 American Home Products 1558 11.0
15 General Electric 1480 1.7116 Trajtenberg
scientists and engineers, such a policy is one that stimulates demand,
implicitly assuming that supply is sufficiently elastic to provide the ad-
ditional personnel called forth by the government-supported R&D.
Figure 3.6 casts serious doubt on this set of premises52: wages of R&D
personnel in the business sector have risen extremely fast in the second
half of the 1990s, much faster than economy-wide wages (by 1999 the
index of wages in R&D had risen 54% more than all wages). Clearly, the
dramatic increase in R&D outlays by the business sector during the
same period fueled the inflation in wages of R&D workers. Mirroring
these developments, there is plenty of circumstantial evidence of se-
vere shortages of computer scientists and engineers, software develop-
ers, and related personnel. The picture that emerges is thus of a very
inelastic supply curve for qualified R&D workers in recent years, which
implies that any additional financial resources channeled into BSRD
would achieve little increase in real R&D in the short run, and instead
would keep fueling wage inflation (see Goolsbee (1998) for a similar ar-
gument regarding the effect of government- supported R&D in the
U.S.).
Shortages of highly skified personnel in cutting edge technologies
seem to be a pervasive, worldwide phenomenon in recent years, cer-
tainly in the U.S. as well as in leading European countries.53 Romer
(2000) suggests that existing institutional arrangement in the U.S.
higher education system limits the supply response to these market
signals, and hence necessitates corrective policy changes. In essence,
the incentive system within universities is not necessarily conducive to
the timely supply of graduates in fields of high demand, with regard to
the number of students admitted to different fields, the mix of courses
offered, the channeling of graduate students into lengthy, often
dead-end postdoc positions, etc.54 Thus, Romer advocates a shift of fo-
cus in government R&D policy, from the traditional subsidization of
R&D itself, which stimulates the demand for scientists and engineers, to
programs that would directly encourage the supply of newly trained
qualified manpower. In light of the trends depicted in figure 3.6, it is
clear that government policy towards R&D in Israel ought to address
both sides of the market: the relative abundance of qualified man-
power is no longer to be taken for granted, and there are plenty of insti-
tutional rigidities and frictions in the educational system to cast doubt
on its ability to respond by itself in a timely fashion to market needs.
One specific problem in Israel, in this respect, is that there are rela-








Index of wages for R&D personnel in Israel relative to average wages (1994: 100).
Source: Israeli Central Bureau of Statistics.
els of general human capital, but not the skills that are required for the
high-tech sector, and that essentially do not participate in the relevant
labor markets. These are primarily ultraorthodox Jews, Israeli Arabs,
and residents in the "development towns" located in the geographi-
cally more distant areas. The impediments to their partaking in the job
opporftmities offered by the new economy are numerous, ranging from
cultural barriers to geographical isolation. It is clear that tapping their
potential could alleviate the shortages mentioned, and at the same time
improve the economic standing of these groups.55 This would involve
providing the appropriate training, setting up an institutional frame-
work that would allow their employment in the high-tech sector with-
out violating their cultural sensitivities, and investing in infrastructure
to bring them closer to the centers of economic activity.
The case of Bangalore in India exemplifies the wide range of possibil-
ities opened for employing skified labor in R&D-related activities from
a distance, without the workers having to migrate and adapt to the en-
vironment of the employer. Indeed, as documented in Arora and
Arunachalam (2000), a large part of the burgeoning software sector in
India does subcontracting development work for U.S.-based firms. It
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would seem that a similar model could be applied within Israel for the
population groups mentioned above, that is, provide them with train-
ing in situ, and employ them in their communities via subcontracting
employment relationships. There seem to be a host of coordination fail-
ures that prevent that from happening without intervention, and hence
there is room for the government to undertake a facilitating role.
Developments in the labor markets associated with high tech have of
course wider implications. In fact, one of the most striking trends in the
Israeli economy of the past two decades has been the rapid rise in
pretax income inequality. Attempts by the government to keep a lid on
after-tax inequality have necessitated a dramatic increase in the share
of the budget (and of GDP) going to welfare, a trend that seems unsus-
tainable. The rapid rise in the relative wages of workers in the
high-tech sector has undoubtedly contributed to the growing income
gap in recent years. Clearly, policies that shift up the demand for these
workers would further increase inequality, at least in the short run,
whereas policies that stimulate the supply response would presumably
do the opposite. This is obviously a normative issue, and hence it lies
well beyond the scope of this paper. However, what is becoming in-
creasingly clear is that, as the sectors and activities associated with ad-
vanced technologies gain in importance throughout the economy,
policies towards them will have to be guided by a wider set of consid-
erations, including their distributive implications.
IV.Issues in the Design of R&D Policies: Drawing from the Israeli
Experience
How Much Total R&D?
The close-up examination of R&D policy in Israel, and in particular the
need to confront the issue of how much the government should allo-
cate to R&D support, brings to the surface the more fundamental prob-
lem of how much resources an economy should devote to R&D: after
all, government support is meant first and foremost to make up for the
presumed underinvestment in R&D by the market, given the gap be-
tween social and private returns to R&D. It is interesting to note that
this issue has not received nearly as much attention as it should have,
either in policy discussions or in economic research. And what a differ-
ence it could make: if for example we take at face value the findings in
Jones and Williams (1998), they imply that the U.S. would have at least
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anything like the optimal R&D/GDP ratio. In fact, the problem may be
worse than that: as shown above for Israel, commonly used deflators
for R&D may not accurately reflect changes in the purchasing power of
R&D dollars, in view of the escalating costs of R&D personnel. In the
U.S. the problem is likely compounded by the fact that a significant
fraction of the compensation to R&D personnel consists of options and
similar devices tied to the stock market that are hard to evaluate and
translate into wage-equivalent figures.
Total R&D in the U.S. has risen significantly in recent years, the an-
nual number of U.S. patents granted has doubled during the decade of
the 1990s (both the total and those assigned to U.S. inventors), and by
any standard the high-tech sector in the U.S. has been booming. Thus,
it would seem that the U.S. is devoting plenty of resources to innova-
tion and technical change, and hence it is tempting to think that there is
no reason for concern in that respect. However, "a lot" does not neces-
sarily imply "enough," and as to R&D/GDP ratios, it may well be that
what was reasonable for the late twentieth century is no longer appro-
priate for the era of the Internet and the new economy. Vannevar
Bush's landmark report "Science: the Endless Frontier" (1945) brought
about a dramatic revision of the role of government in supporting sci-
ence and technology and a steep rise in the resources committed to
R&D. By the 1960s a R&D/GNP ratio of about 2.9% seemed perfectly
natural, and certainly not excessive, even though it constituted a dou-
bling of that ratio from the early 1950s.56 It may well be the case that a
new revision is called for, but much more serious research would have
to be done in order to come up with sound policy recommendations in
that respect.
Supply vs. Demand
As shown in the subsection "Prop Up Demand, or Stimulate Supply?"
of Section III, the wages of R&D personnel skyrocketed in Israel, rising
50% faster than average wages, during the second half of the 1990s.
This meant first and foremost that actual R&D performed rose much
more slowly than implied by the official statistics (using sectoral
deflators). Second, and perhaps more importantly, wage inflation in
R&D implies that the basic premise underlying the type of R&D policy
conducted in Israel might be flawed. That is, the support of the de-
mand side (in the market for R&D inputs, and in particular of scientists
and engineers) may run into an inelastic supply schedule, leading just
to wage escalation rather than to real increases in the amount of R&D120 Trajtenberg
performed (which is the intent of the policy). Even without significant
government support to the demand side, the supply elasticity may be
an issue of concern for the setting of national policy in that regard,
since the ability of the economy to innovate over the long run depends
to a significant extent on such e1asticity Once again, the case of Israel
can be seen as a laboratory where these effects are more pronounced
(both the extent of support to the demand side, and the steepness
of the rise in R&D wages), and hence may well constitute an early
warning.
Romer (2000) examines various policy options for the U.S. in that re-
gard, and I shall not go into them here. Let me mention two issues that
I believe require further attention. As mentioned above, there are some
segments of the population in Israel that have been completely by-
passed by the rapid development of the high-tech sector. One of the im-
plications is that the effective pool of workers that could feed into the
rapidly advancing, R&D-intensive sectors is significantly smaller than
it could be if those segments were somehow incorporated in it.It
would seem that something similar happens in the U.S., with respect to
some minorities, immigrant groups, and geographical locations. Of
course, segmentation occurs primarily along educational lines, and
hence one could treat it as part of the wider problems of skill acquisi-
tion, the (in)effectiveness of the educational system, the inequalities
that arise in that context, etc. What I am suggesting is that these issues
have to be thought about also in the context of the elasticity of supply
facing the innovative sectors of the economy, and hence in the context
of R&D policy. That is, an issue of primary interest is the availability of
qualified manpower to support the rapid expansion of the high-tech
sector and the structural changes that are occurring throughout the
economy as information technologies are incorporated in a massive
way by user sectors. All these put a great strain on the market for
high-skilled workers, and the ability to keep innovating depends to a
large extent on the capacity of the economy to incorporate into the pooi
of relevant workers wider and wider segments of the population.
R&D policies have traditionally been mostly concerned with just
incentivizing and financing the demand sidea more balanced ap-
proach that also addresses the supply side is called for.
Types ofSupportforR&D
One of the interesting features of government support programs in Is-
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was upgraded and started to operate in earnest (following the passage
of the Law for the Encouragement of R&D), there have been a series of
changes that greatly expanded the menu of support programs. The
core program remained the matching funds for commercial R&D pro-
jects, but there were two important additions57: the Incubators program
and the Magnet program. Beyond the OCS's programs, the govern-
ment established Yozma, the initiative to jump-start the venture capital
market. The Incubators program was meant to support the very early
stages of entrepreneurial, innovative projects, whereas the Magnet pro-
gram was aimed at consortia of established firms with academia, tar-
geting generic, precompetitive projects. The point is that the complex
and arduous process that leads from an original idea to a successful
commercial innovation may meet a series of market failures along the
way, and no single program, aimed at a particular stage in that se-
quence, can hope to solve them all or even most of them. Moreover, the
object of R&D policy, namely innovation and innovative sectors, is by
definition extremely dynamic, its structure and needs being in constant
flux. Thus, R&D policies have to respond in kind if they are to remain
relevant and serve their stated purpose.
One of the interesting aspects of the Magnet program is that whereas
its overt objective was to move up the ladder and support more basic
R&D (i.e. more generic projects), it is quite clear ex post that one of its
main achievements may be in overcoming coordination and informa-
tional failures that turned out to be rampant. It seems that it also facili-
tates to a significant extent the spread of spillovers among relevant
players, but that is something that requires further scrutiny. Bringing to
the surface these coordination and informational problems was an im-
portant (if mostly unintended) outcome of the program, and they in
turn pose a challenge to the design of further policies. The Israeli expe-
rience in this regard raises the question of the extent to which such
problems are present also in the U.S., and what sort of policies may be
tailored to address them.
Another important aspect of Magnet is the building of bridges be-
tween academia and industry. This has become an increasingly impor-
tant issue in advanced economics, and certainly in the U.S. An
interesting aspect of the Magnet model is that the connection with aca-
demia is through a consortium of firms, and not by individual firms.
One advantage of this approach is that it makes it easier to preserve the
independence and freedom of the academic researchers, both because
there are multiple players on the other side and because the whole ar-
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A further aspect of the dynamism required from the R&D support
system is the ability to recognize in real time the changing nature of the
technologies to be supported. This mirrors to a large extent the need of
the Patent Office to update the coverage of what is deemed patentable.
A typical example is software development, which in Israel became eli-
gible for support sometime during the 1990s,58 and the current debate
on targeting biotechnology.
The case of Yozma, the government-sponsored institution that
jump-started the venture capital market in Israel, is a remarkable tale
of prompt and expedient government intervention that served as
catalyst and marketmaker. The point here is that, even in areas that
surely are better left to the market, government policy may play a
(temporary and well-delimited) role in speeding up processes that
might have happened by themselves, but not necessarily at the
right time and/or to the extent required from a social returns point of
view. There are undoubtedly positive externalities in setting up new
markets (such as the venture capital market), which may lead to timing
failures.
Mechanisms of Support
Once again, the Israeli experience brings to the table a whole range of
issues regarding mechanisms of support to R&D, for given policies,
which may be relevant for the U.S. One is project selection: as men-
tioned above, until not long ago virtually all R&D projects that met cer-
tain threshold criteria became eligible for matching funds (which
implied de facto budget accommodation), whereas in the past few
years a rigid budget constraint has been forcing a switch towards ex-
plicit selection mechanisms, in view of excess demand for support.
One of the most difficult issues to confront in this context is how to
preserve neutrality once a ranking system is introduced, given the
difficulties in making cross-field comparisons (how would one rank,
say, the top project in biotechnology vis-à-vis the top project in fiber op-
tics?). A layered decision-making system may be called for (e.g., decide
first how much to support each field, then allocate within), but then the
inputs into such a system would have to be far more than just expert
referee reports on individual projects. A related issue is randomization:
as suggested in the sub-subsection "Allocation Schemes for the Regu-
lar OCS Program of R&D Grants" in Section III, this may be a very at-
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political feasibilityit may well be that this is currently a more viable
option in the U.S. than in Israel.
Another issue for which Israeli R&D policy can provide an interest-
ing case study is the payback system (to the best of my knowledge
this aspect of the program is unique to Israel). Both proponents and
opponents of the introduction of such a system in the U.S. can look
closely at Israel's experience and learn from it. An aspect that we find
particularly troubling is that of political opportunism, which clearly
was at work in Israel. That is, the actual budget of R&D support (i.e. the
nominal budget minus the amount collected as paybacks) remained
steady in the second half of the 1990s, and even declined slightly, but
that was not a known fact: overtly the government was increasing the
budget, and thus shielded itself from political pressure to increase it
further.
International Spillovers
One of the most perplexing aspects of R&D policy lies in the fact that
the fruits of innovative activities do not stop at country borders, but to
some extent benefit also consumers and producers in other countries.
Of course, no government wants to use tax dollars to subsidize citizens
from other countries. The issue is therefore one of extent, and of
trade-offs: if the local benefits are very large relative to spilovers to
other countries, then the support may be amply justified, but not if the
benefits accrue mostly to outsiders. The main trade-off in any case
is with openness and the benefits from globalization: attempts to
keep the benefits at home, by somehow restricting access, are bound
to impair also the inflows (in terms of trade, investment, and also
technology).
Contrary to Israel, the U.S. is in the enviable position of seemingly
being the recipient of substantial inflows from abroad, particularly in
that there is a steady "brain gain" from other countries into the U.S., at-
tracted by the lure of Silicon Valley, the fact that the main markets for
technologically advanced products are mostly in the U.S., the availabil-
ity of capital (e.g. Nasdaq), etc. At the same time, the rest of the world
benefits of course from innovation in the U.S.59 R&D policy in the U.S.
should take these flows into account; thus for example, if the inflows
are very substantial, there may be a multiplier effect, in that every dol-
lar invested in R&D in the U.S. may bring in additional innovation by
attracting further innovative inputs into the country The implicationsof such an effect for government support of R&D could go either way,
and certainly deserve further study.
V.Concluding Remarks
Israel constitutes an interesting laboratory case of government inter-
vention in the realm of R&D policy. The recognized potential of the
country in terms of scientific and technological prowess was leveraged
by extensive government support to commercial R&D projects, at a
time when capital markets in Israel were very limited and geopolitical
factors hampered the development of export-oriented industrial sec-
tors. The principle of neutrality that governed the main support pro-
grams ensured that resources allocated responded to market signals
rather than to bureaucratic directives.
The Office of the Chief Scientist proved to be very dynamic and re-
sponsive to changing circumstances, instituting from 1985 to the early
1990s a series of innovative programs that addressed emerging needs:
Yozma, the government-sponsored venture capital fund that set the
stage for the advent of private venture capital (and dissolved itself
shortly after that started to happen on a significant scale); the Incuba-
tors program, which responded both to the opportunity opened up by
the mass immigration of scientists and skilled workers from the former
Soviet Union, and to the realization that a whole set of market failures
might occur at earlier stages, before a firm could qualify for support
from the regular OCS program; the Magnet program, designed to sup-
port generic, precompetitive, long-term projects conducted by consor-
tia of firms and academia, and in so doing plays a role in facilitating the
tapping of scientific knowledge in academia for industrial purposes,
and in remedying coordination failures within industry; programs that
encourage international cooperation; etc.
And indeed, available indicators show that the high-tech sector in Is-
rael has flourished and grown remarkably quickly since the mid-1980s.
Thus, the number of U.S. patents granted to Israeli inventors has more
than tripled since 1985, making Israel one of the leading countries in
patents per capita. Key to this impressive growth, the share of patents
in computers and communications, the leading sector of the new econ-
omy has zoomed from 8% to 27% of all Israeli patents. Likewise, Israeli
high-tech exports grew eightfold from 1988 to 2000 (from $1.2 to $9.6
billion), doubling their share of total exports to over a third. Several
studies have tried to examine the extent to which government policies
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contributed to this success. Even if still tentative, available evidence
suggests that they contributed significantly in various ways, including
the vast expansion of capital markets, a positive effect of government
grants on productivity growth, and the further stimulation of R&D
spending (additionality).
The very success of the high-tech sector, and arguably also of the un-
derlying policies, poses new challenges that need to be addressed. The
budget for support of R&D grew in tandem with the growth of the sec-
tor, but by the late 1990s it had become sufficiently large to turn into a
macro issue. Given the prevailing fiscal restraint, the government es-
sentially froze the OCS budget, and thus brought into sharp focus the
question of how to allocate these now scarce funds to a much larger
pool of support applications (that qualify for support according to pre-
vailing criteria). Options include instituting a competitive ranking sys-
tem, randomization, and explicit departures from neutrality in other
dimensions, such as differential support according to size of firms. Be-
yond allocation mechanisms, the more fundamental issue is that of set-
ting a target R&D/GDP ratio, and deriving from it the optimal level of
total R&D support.
The rapid growth of the R&D sector eventually ran into what proved
to be a highly inelastic segment of the supply of qualified manpower,
inflating wages for R&D personnel, and thus putting a cap on the ac-
tual growth of innovational efforts. Clearly, government policies will
have to address both sides of the market for R&D inputs if they are to
be effective. In so doing, they should consider how to bring into the
realm of high tech sements of the population (and areas of the coun-
try) that so far have been left out. Further open issues include the pay-
back provision (which risks political opportunism), the requirement of
production in Israel, which may end up subsidizing inefficient local
production, the extent to which support should be directed to more ba-
sic research, etc.
One way of summarizing the Israeli experience is to point out that
the key to the apparent success of R&D policies seems to have been
both boldness in the deployment of resources, and flexibffity and cre-
ativity (i.e. innovativeness) in responding to rapidly changing needs
and challenges, many of them the product of earlier successes. Given
the inherent dynamism of the high-tech sector, any policy that follows
rigid rules is bound to rapidly become ineffective and/or inefficient.
Thus, if the institutional setting does not allow for a speedy process of
adaptation and innovation in policy design, it may be better not to126 Trajtenberg
intervene to begin with. As described in section IV, much of this is of
potential relevance for any country seeking an active role for govern-
ment in the realm of advanced technology and innovation.
Appendix. R&D Figures and Ratios: Measurement Problems
Ever since the publication and widespread adoption of the Frascati
Manual in the 1980s, there has been remarkable progress in achieving
international harmonization in terms of what constitutes R&D. How-
ever, the changing nature of innovative activities poses renewed prob-
lems at every turn, as is the case for example with many types of
software development and Internet-related innovations.60 Prompted by
the sense that existing data collection procedures failed to take account
of substantial portions of R&D activities, the Israeli Central Bureau of
Statistics (CBS) introduced in the late nineties a new and much more
detailed survey of Business Sector R&D (BSRD), which resulted in
drastic revisions of previously available estimates. Thus, for example,
the newly computed BSRD for 1997 was 44% higher than the previous
estimate, and as a consequence the R&D/GDP ratio jumped up by
about half a percentage point to 3.1% for that year, reaching 3.5% in
1999.61
The revision that the CBS has undertaken exemplifies the difficulties
of setting policy according to these ratios: until the publication of the
revised figures, existing estimates indicated that Israel's R&D/GDP
was about average relative to the OECD, and moreover, that Israel's
BSRD constituted a significantly smaller proportion of total R&D than
in other countries (about 50-55%, compared to a median of 62% for the
OECD). Thus, if these ratios were used as yardsticks for policy, it
would have been reasonable to advocate further support to BSRD so as
to increase its share, a move that would have resulted also in a moder-
ate increase in the R&D/GDP ratio.62 The current figures put Israel at
the upper end of OECD countries in R&D/GDP ratio, and about aver-
age in BSRD/R&D. Thus, international comparisons of this sort would
suggest at present very different policy recommendations.
The second measurement problem is that of devising appropriate
deflators for R&D expenditures. The practice at the CBS has been to
compute for each R&D-performing sector an index based on the aver-
age wages in the sector on the one hand, and the costs of materials and
capital outlays on the other hand (each component weighted by its ap-
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Table 3.8
Annual average rate of growth of BSRD: 1994-1999 (using revised figures based on new
CBS survey).
aprovjsjonal computations; approximate only.
rately by the CBS (as part of its general survey of labor and wages),
indicates that wages for R&D personnel in the business sector rose much
faster than average wages in the sector. Thus, computing a deflator
based on these wages renders a very different picture, as can be seen in
the comparison in table 3.8.63
The impressive growth of BSRD in the past half decade (12% per
year, CPI-adjusted) is thus greatly attenuated on deflating it by the new
and still provisional index: only about 3% per year. Of course, the
R&D/GDP ratio would be significantly lower as well if we were to
compute it on the basis of these "real" magnitudes. Once again, these
disparities are just meant to illustrate the extent to which the figures
that might serve us as guideposts for policy are sensitive to the way we
treat these measurement issues.
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This paper draws extensively from and constitutes a follow-up to Trajtenberg (2000).
See for example Klette, Moen and Griliches (1999), David and Hall (2000), and Jones
and Williams (1998).
However, R&D policy in Israel has virtually stalled since the late 1990s in view of
mounting challenges, and it remains to be seen whether policymaking in this area wifi re-
veal the same degree of creativity in dealing with them as it did in the past.
In nominal Israeli shekels 21%
Deflated by the CPI 12%
Deflated by the CBS R&D deflator
(1994-98, prior to revision) 7%
Deflated by new index based on wages
of R&D personnel in business sectora128 Trajtenberg
As the title indicates, we confine ourselves to civilian, industrial R&D. Both defense
R&D and academic R&D have played all along a pivotal role in Israel's overall research
enterprise, and fueled to some extent the growth of high tech via a variety of spillovers,
but these are beyond the scope of this paper.
We draw for this section from a variety of material from the OCS (see Israel Ministry
of Industry and Trade, 1994, 1999a, 1999b, 1999c), as well as from personal involvement
with the OCS, in particular with the Magnet program.
Actually the original payback schedule was as follows: 3% of revenues from sales of
the products developed for the first 3 years, 4% in the next three years, and 5% from the
seventh year onwards. This schedule has been revised a few times, and the Treasury has
long been pressuring the OCS to increase these percentages, and even impose interest
payments.
The Research Committee may grant exemptions to requirements (2) and (3), but as far
as I have been able to establish, this has rarely happened.
In the early 1990s the 1985 law was amended so as to place the software industry on
an equal footing with other industrial sectors, so that software development projects
qualify for the same type of aid.
Israeli universities have also proved to be highly capable of generating innovations
having economic potential (as manifested for example in the large number of U.S. pat-
ents assigned to themsee Trajtenberg (1999)), but once again weak links with industry
have prevented the extensive exploitation of such potential.
"Magnet" is an acronym (in Hebrew) for "generic, precompetitive research".
Magnet also supports the integration of advanced technologies into industry via us-
ers' associations, but that is a secondary activity.
Participation is limited to Israeli-based companies and Israeli subsidiaries of foreign
companies.
In addition to the sources already mentioned, we drew material for this section from
the Internet site of the program, www.incubators.org.il.
Each incubator is an autonomous not-for-profit organization. Day-to-day operations
are run by a professional (salaried) manager, and next to her operates a projects commit-
tee that selects and monitors the projects. These committees are composed of profession-
als from industry and academia, such as corporate executives, R&D managers, and
professors. Committee members volunteer their time and expertise and do not receive
any financial compensation.
The budget for the incubator's administration is $175,000 per year. This includes the
incubator manager's salary, administrative expenses, outlays for sorting and studying of
ideas, and organizational expenses for project commercialization and marketing.
The data come from the office of Lidia Lazens of the OCS, and were supplied by Shai
Goldberg.
The dollar figures in tables 3.1 and 3.2 are all in current dollars; in order to transform
them into constant dollars one would have to construct an appropriate R&D deflator, of
which the main component would be of course the wages of R&D personnel (see the
sub-subsection "R&D Ratios as Yardsticks for Policy" in section III). Lacking at present a
reliable deflator, and rather than using ready-made but potentially misleading price indi-
ces, we opt here to leave the figures in current dollars (a common practice is to deflate justGovernment Support for Commercial R&D 129
by the rate of inflation in the U.S., but such a deflator is in fact irrelevant for the case at
hand). Thus, all statements henceforth implying comparisons of dollar figures across
time need to be qualified, since these figures are not really in the same units.
The projections for 2000 indicate that paybacks may have stabilized by now.
Startups are defined by the OCS as finns up to 3 years of age.
There are no official figures in that respect, but all indications are that startups have
mushroomed in Israel since the mid-1990s. In fact, a recent newspaper report based on
the number of startups that hired the services of accounting firms claimed that in 1999
alone 1500 new startups were formed.
This might also reflect a change in the technology mix of the newcomers, with more
of them in Internet applications that represent novel business models rather than novel
technology, and hence that may not qualify for support from the OCS.
Large firms are defined by the OCS as those with over $100 million in sales; startups
are firms up to 3 years of age.
In table 3.6 some dollar series are aggregated into 5-year totals: these sums obviously
don't mean much, since the figures are in nominal dollars, but may still be useful asrough
bases of comparison across firms of different sizes.
This figure refers to projects approved. The average number of projects applied for is
about 1800.
This was a deliberate policy decision by the OCS, meant to cope with the excess de-
mand for support in view of the budget cap imposed by the Treasury.
A report prepared for the OCS in 1999 claimed that large firms commanded 56%of
the OCS budget during the period 1985-94. If so, there is a declining trend, beyondthe
one-time policy shift in 1999. However, the figures are not strictly comparable, andhence
we cannot assert this with certainty.
David, Hall, and Toole (1999) survey a body of recent empirical studies, but do not
find robust patterns that could be generalized. On the other hand, using a cross-country,
macroeconomic model, Guellec and Van Pottelsberghe (2000) find evidence of significant
additionality effects for 17 OECD countries.
See also Israel CBS (1999a) for further detailed statistics on "advanced" versus tradi-
tional sectors.
Thus the advanced sectors include for example electronics and electrical, the mixed
ones construction-related industries, and the traditional onestextiles and apparel.
This section consists of excerpts from Trajtenberg (1999).
The in-between flat period of 1987-91 (which represents R&D activity done circa
1985-89) presumably reflects the big macro adjustment and micro restructuring that fol-
lowed the stabilization program of 1985.
The R&D figures are from Griliches and Regev (1999, table 1). Since these refer to in-
dustrial R&D, it may be more appropriate to relate them to Israeli corporate patents than to
total patents. In practice the two patent series move pretty much in tandem, and hence
the correlations with R&D of either series are virtually the same.
Patent applications reflect (successful) R&D conducted prior to the filing date,
with lags varying by sector. Thus, the number of patents in a particular year shouldbe130 Trajtenberg
attributed to investments in R&D carried out in the previous 1-2years at least, and in
some sectors further back.
The reference group was chosen according to their GDP per capita in the early 1990s,
that is, we chose the four countries that had at that time a level of GDP per capita closest
to that of Israel (in purchasing power parity terms). Notice that, except for Spain, the
countries in this group are also very similar to Israel in population.
Another normalization of interest would be R&D expenditures, but except for the
G7, the figures are far from satisfactory.
As mentioned in the introduction, a great deal of research on R&D policy has been
done recently. Aside from the references mentioned there, see also David, Hall, and Toole
(1999), Hunt and Tybout (1998), and Klette and Moen (1998a, 1998b).
Apparently this was the first time in the history of the OCS that demand exceeded
the budget provision by a substantial amount.
Indeed, in January2000 the government initiated a move aimed at revising the R&D
Law.
Some projections indicate that would be true even if the budget were increased sub-
stantially.
It is quite likely that the present system in actuality is not neutral either, but the lack
of neutrality is disguised. In a ranking system the issue rises to the surface and will have
to be addressed head on.
It is interesting to note that there is a great deal of interest in this policy both in the
U.S. and in Europe, and it would seem that at some point some version of randomization
will be implemented. One of the great advantages (in the long run) of sucha policy is that
it allows for methodologically sound assessment studies of the efficacy of government
support (since the control sample is built-in).
In fact, it would seem that, while formally neutral, actual support policies favored
particular technological areas, primarily electronics, and (until the mid-1990s) large firms
over smaller ones (see below).
Except for the Incubators program, as described in Section II.
By startups we mean young, small ongoing firms, not those that are still in the incu-
bator phase.
The percentage was set at 3%, but there have been several attempts by the Treasury
to raise it further (to 4.5%), and even to charge interest on the principal. In fact, the Trea-
sury has been promoting the idea that the grants should turn into conditional loans,
which will serve as a way of overcoming financial constraints on R&D firms, but notas a
straight R&D subsidy.
Consider that the OCS has dealt with R&D projects of about 3000 firms in the past 15
years, and keep in mind that, as said before, the whole business sector R&D of Israel
amounts to that done by the 8th largest R&D spender in the U.S., Johnson and Johnson
(see table 3.7).
I was a member of the Board of Directors of Magnet, and in that capacity I have wit-
nessed many times this sort of failure, not only between firms but also between firms and
academia. One of the most striking was the case of the digital printing consortium: the
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search on properties of ink that was being conducted at some academic institutions in Is-
rael (virtually next door).
The high-tech sector is actually split in this respect: on the one hand the traditional
electronics sector demands bigger budgets for the OCS; on the other hand, Internet-
related ventures and some of the new software developers lobby instead for favorable
tax breaks, particularly with regard to capital gains.
Thus, advocating a move towards the mean R&D/GDP ratio of a "relevant" group of
countries is politically easier to justify than persistent divergence from such reference
ratios.
If one could compute an optimal R&D/GDP ratio for different countries, chances are
that it would be a concave, decreasing function of size.
These figures are based on the revised estimates produced by the CBS on the basis of
its new survey. The previous estimates placed Israel much lower on that scale: 16th in
BSRD, and 7th in total R&D.
All this refers to developments up until the last quarter of 2000: the economic down-
turn that started then may have temporary halted or perhaps even reversed some of
these trends.
One of the related, hotly debated policy issues in many countries is the extent to
which foreign high-tech workers should be allowed in. This has also become a highly
controversial issue in Israel.
Romer's view would seem to contradict Rosenberg's (1999, 2000), who has persua-
sively argued that one of the key sources of strength underlying the technological and
scientific prowess of the U.S. has been the responsiveness of universities to market needs
and new technological developments. However, it could well be that what had character-
ized universities throughout most of the twentieth century does not quite hold in recent
years, and/or that the pace of change has accelerated, and hence the response of univer-
sities seems more sluggish now.
These are mostly in the lowest income brackets, and account for a large fraction of
the unemployed.
See Mowery and Rosenberg (1989, table 6.2, p. 127): the R&D/GNP ratio was 1.4 in
1953, and climbed rapidly to about 2.9 in the mid-1960s.
There were other changes and additions, but these two constitute the most dramatic
expansion of the policy menu.
We could not ascertain exactly when that happened, but it surely was before the late
1990s.
See Coe and Helpman (1995), and Bayoumi, Coe, and Helpman (1999): they show
that productivity growth in other countries is an increasing function of the R&D done in
the U.S., mediated by trade flows. Such cross-influences exist for most advanced coun-
tries, but the sheer size of U.S. R&D is such that it becomes a dominant factor for many
other countries.
Regarding the Internet, it is often hard to distinguish between developments that are
purely the result of entrepreneurship and those that are the outcome of R&D as tradition-
ally defined.132 Trajtenberg
These are the latest (and still preliminary) ratios computed by CBS for international
comparisons. Israel CBS (1999b) reports a R&D/GDP ratio of 2.3 for 1996, the latest such
official figure there. The revisions put the figure for that year at 2.8, so the increase in the
ratio due to the new survey is at least half a percentage point.
See for example an earlier version of this paper, Trajtenberg (2000).
We inflated the old 1996 figure by a factor of 1.44 (recall that the new estimate for
BSRD 1997 was 44% higher than the previous one) in order to compute the rate of change
for 1996-97. From then on we used the new figures.
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